Login to Your Account

Antibiotics, Antivirals Still Hold Appeal For VCs In Tight Market

By Randall Osborne

Monday, January 6, 2003
Year-end retrospectives aside, taking the figurative pulse of an industry as large and varied as biotechnology is anything but easy. But during what everybody acknowledges were tight economic times, a notable trend was the continued interest by venture capital, especially in the field of anti-infectives. (BioWorld Financial Watch)

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription